Management of psoriasis as a systemic disease: what is the evidence?
NJ Korman - British Journal of Dermatology, 2020 - academic.oup.com
Background Psoriasis is a chronic, systemic immune‐mediated disease characterized by
development of erythematous, indurated, scaly, pruritic and often painful skin plaques …
development of erythematous, indurated, scaly, pruritic and often painful skin plaques …
[HTML][HTML] Neutrophils in psoriasis
Neutrophils are the most abundant innate immune cells. The pathogenic roles of neutrophils
are related to chronic inflammation and autoimmune diseases. Psoriasis is a chronic …
are related to chronic inflammation and autoimmune diseases. Psoriasis is a chronic …
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 1: treatment and monitoring recommendations
A Nast, C Smith, PI Spuls, G Avila Valle… - Journal of the …, 2020 - Wiley Online Library
This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …
developed following the EuroGuiDerm Guideline and Consensus Statement Development …
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 2: specific clinical and comorbid situations
A Nast, C Smith, PI Spuls, G Avila Valle… - Journal of the …, 2021 - Wiley Online Library
This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …
developed following the EuroGuiDerm Guideline and Consensus Statement Development …
[HTML][HTML] Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
High-throughput metabolite profiling provides the opportunity to reveal metabolic
mechanisms and identify biomarkers. Psoriasis is an immune-mediated chronic …
mechanisms and identify biomarkers. Psoriasis is an immune-mediated chronic …
[HTML][HTML] Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis
F Bai, W Zheng, Y Dong, J Wang, MA Garstka, R Li… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Materials and Methods A comprehensive literature search was performed in PubMed,
ScienceDirect and Web of Science for the available relevant studies published before …
ScienceDirect and Web of Science for the available relevant studies published before …
Diet and physical exercise in psoriasis: a randomized controlled trial
Background Increased body mass index and weight gain are risk factors for psoriasis, and
the prevalence of obesity in patients with psoriasis is higher than in the general population …
the prevalence of obesity in patients with psoriasis is higher than in the general population …
Chemerin/chemR23 axis in inflammation onset and resolution
F Mariani, L Roncucci - Inflammation Research, 2015 - Springer
Chemerin is an adipokine secreted by adipocytes and associated with obesity, insulin
resistance and metabolic syndrome. Different chemerin fragments with pro-or anti …
resistance and metabolic syndrome. Different chemerin fragments with pro-or anti …
[HTML][HTML] The role of adipokines in the pathogenesis of psoriasis
K Kiełbowski, E Bakinowska, P Ostrowski… - International Journal of …, 2023 - mdpi.com
Psoriasis is a chronic and immune-mediated skin condition characterized by pro-
inflammatory cytokines and keratinocyte hyperproliferation. Dendritic cells, T lymphocytes …
inflammatory cytokines and keratinocyte hyperproliferation. Dendritic cells, T lymphocytes …
Serum leptin, resistin, and adiponectin concentrations in psoriasis: a meta-analysis of observational studies
A Kyriakou, A Patsatsi, D Sotiriadis, DG Goulis - Dermatology, 2018 - karger.com
Background: Psoriasis is an immune-mediated, inflammatory disease. Adipokines contribute
to the regulation of immune-mediated processes and inflammation. Objective: The aim of our …
to the regulation of immune-mediated processes and inflammation. Objective: The aim of our …